New clinical data surrounding the medication Retatrutide , specifically the 120 milligram formulation ZPHC ZPHC, reveal a significant effect on weight loss and linked metabolic conditions . Experts posit that this innovative compound, affecting both GLP-1 and GIP receptors , has the potential to offer a major advance in the management of excess we